BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17911342)

  • 1. Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats.
    Obrosova IG; Drel VR; Oltman CL; Mashtalir N; Tibrewala J; Groves JT; Yorek MA
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1645-55. PubMed ID: 17911342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice.
    Drel VR; Pacher P; Vareniuk I; Pavlov I; Ilnytska O; Lyzogubov VV; Tibrewala J; Groves JT; Obrosova IG
    Eur J Pharmacol; 2007 Aug; 569(1-2):48-58. PubMed ID: 17644085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst.
    Obrosova IG; Mabley JG; Zsengellér Z; Charniauskaya T; Abatan OI; Groves JT; Szabó C
    FASEB J; 2005 Mar; 19(3):401-3. PubMed ID: 15611153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice.
    Vareniuk I; Pavlov IA; Drel VR; Lyzogubov VV; Ilnytska O; Bell SR; Tibrewala J; Groves JT; Obrosova IG
    Exp Neurol; 2007 Jun; 205(2):425-36. PubMed ID: 17475250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the peroxynitrite decomposition catalyst Fe(III) tetra-mesitylporphyrin octasulfonate on peripheral neuropathy in a mouse model of type 1 diabetes.
    Drel VR; Pacher P; Vareniuk I; Pavlov IA; Ilnytska O; Lyzogubov VV; Bell SR; Groves JT; Obrosova IG
    Int J Mol Med; 2007 Dec; 20(6):783-92. PubMed ID: 17982684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Salvemini D; Yorek MA
    Br J Pharmacol; 2001 Sep; 134(1):21-9. PubMed ID: 11522593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amelioration of neurological and biochemical deficits by peroxynitrite decomposition catalysts in experimental diabetic neuropathy.
    Arora M; Kumar A; Kaundal RK; Sharma SS
    Eur J Pharmacol; 2008 Oct; 596(1-3):77-83. PubMed ID: 18768138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Na+/H+ exchanger 1 inhibition reverses manifestation of peripheral diabetic neuropathy in type 1 diabetic rats.
    Lupachyk S; Watcho P; Shevalye H; Vareniuk I; Obrosov A; Obrosova IG; Yorek MA
    Am J Physiol Endocrinol Metab; 2013 Aug; 305(3):E396-404. PubMed ID: 23736542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxynitrite and protein nitration in the pathogenesis of diabetic peripheral neuropathy.
    Stavniichuk R; Shevalye H; Lupachyk S; Obrosov A; Groves JT; Obrosova IG; Yorek MA
    Diabetes Metab Res Rev; 2014 Nov; 30(8):669-78. PubMed ID: 24687457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Yorek MA
    Diabetes; 2001 Aug; 50(8):1927-37. PubMed ID: 11473057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy.
    Ilnytska O; Lyzogubov VV; Stevens MJ; Drel VR; Mashtalir N; Pacher P; Yorek MA; Obrosova IG
    Diabetes; 2006 Jun; 55(6):1686-94. PubMed ID: 16731831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral neuropathy in mice with neuronal nitric oxide synthase gene deficiency.
    Vareniuk I; Pacher P; Pavlov IA; Drel VR; Obrosova IG
    Int J Mol Med; 2009 May; 23(5):571-80. PubMed ID: 19360314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.
    Obrosova IG; Pacher P; Szabó C; Zsengeller Z; Hirooka H; Stevens MJ; Yorek MA
    Diabetes; 2005 Jan; 54(1):234-42. PubMed ID: 15616034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
    Pop-Busui R; Sullivan KA; Van Huysen C; Bayer L; Cao X; Towns R; Stevens MJ
    Exp Neurol; 2001 Apr; 168(2):259-72. PubMed ID: 11259114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of streptozotocin-induced diabetic rats with AVE7688, a vasopeptidase inhibitor: effect on vascular and neural disease.
    Davidson EP; Kleinschmidt TL; Oltman CL; Lund DD; Yorek MA
    Diabetes; 2007 Feb; 56(2):355-62. PubMed ID: 17259379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent targeting of nitrosative stress-PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy.
    Negi G; Kumar A; Sharma SS
    Biochem Biophys Res Commun; 2010 Jan; 391(1):102-6. PubMed ID: 19900402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes.
    Vareniuk I; Pavlov IA; Obrosova IG
    Diabetologia; 2008 Nov; 51(11):2126-33. PubMed ID: 18802679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in endoneurial blood flow, motor nerve conduction velocity and vascular relaxation of epineurial arterioles of the sciatic nerve in ZDF-obese diabetic rats.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Yorek MA
    Diabetes Metab Res Rev; 2002; 18(1):49-56. PubMed ID: 11921418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with the xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats.
    Inkster ME; Cotter MA; Cameron NE
    Eur J Pharmacol; 2007 Apr; 561(1-3):63-71. PubMed ID: 17291486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve.
    Coppey LJ; Davidson EP; Dunlap JA; Lund DD; Yorek MA
    Int J Exp Diabetes Res; 2000; 1(2):131-43. PubMed ID: 11469397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.